CU-06

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameCU-06
Drug Alias NameCU-101CU-102CU-103CU-104CU-105 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor inhibitorsInterleukin-1 beta inhibitorsHistamine release inhibitors +[4] 
TargetsProthrombinVascular endothelial growth factorInterleukin-1 beta
Therapy Area/IndicationsDiabetic macular oedemaAngioedemas, HereditaryMyocardial Infarction +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCuracle Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThéa Open InnovationCuracle Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaAngioedemas, HereditaryMyocardial Infarction +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A